Home Procurement NewsKaruna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

December 22, 2023•

Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash.

Was this article helpful?

YesNo

Last modified: December 22, 2023

Previous: Navy recovers N5billion worth of stolen crude oil in one year

Next: Rivers Crisis: Angry Protesters Storm Port Harcourt Over Tinubu’s Intervention (Pictures)

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

The articles and content featured on this platform are sourced from various contributors and do not necessarily reflect the views or positions of Accountability Lab Nigeria. We do not author or edit the published materials. If you have concerns about any content or would like to request its removal, please contact us at @Accountability Lab Nigeria.

Recent Posts

Recent Comments

No comments to show.

Are you ready to join the Community?

Join the Conversation!

Community of Practice Portal aims to bring together key stakeholders in the procurement landscape in Nigeria to leverage on each others skillset in relation to understanding Procurement data in a bid to use these data to create stories and to generate action from the government.

Community of practice platform is an initiative under Anti-Corruption Innovation Project, a UNDP funded Project in collaboration with Accountability lab Nigeria, and Open Contracting Partnerships

Accountability Lab Nigeria

Video Player

Media error: Format(s) not supported or source(s) not found

Download File: https://aclcop.cloudware.ng/wp-content/uploads/2025/03/Aclcop-2.mp4?_=1 Download File: https://aclcop.cloudware.ng/wp-content/uploads/2025/03/Aclcop-2.mp4?_=1

00:00

00:00

00:00

Use Up/Down Arrow keys to increase or decrease volume.

Copyright © 2021 - Accountability Lab Nigeria

Close